2021 SGO建议:妊娠滋养细胞疾病的流行病学,诊断和治疗

2021-10-19 美国妇科肿瘤学会 Gynecol Oncol

2021年10月,美国妇科肿瘤学会(SGO)发布了妊娠滋养细胞疾病的流行病学,诊断和治疗建议。妊娠滋养细胞疾病(GTD)是由异常受精事件引起的一组相互关联性的肿瘤,包括良性、潜在恶性以及恶性三种情况。

中文标题:

2021 SGO建议:妊娠滋养细胞疾病的流行病学,诊断和治疗

英文标题:

Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendation

发布机构:

美国妇科肿瘤学会

发布日期:

2021-10-19

简要介绍:

2021年10月,美国妇科肿瘤学会(SGO)发布了妊娠滋养细胞疾病的流行病学,诊断和治疗建议。妊娠滋养细胞疾病(GTD)是由异常受精事件引起的一组相互关联性的肿瘤,包括良性、潜在恶性以及恶性三种情况。本文主要针对GTD的流行病学,诊断和治疗提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 SGO建议:妊娠滋养细胞疾病的流行病学,诊断和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d03531c002255ed2, title=2021 SGO建议:妊娠滋养细胞疾病的流行病学,诊断和治疗, enTitle=Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendation, guiderFrom=Gynecol Oncol, authorId=0, author=, summary=2021年10月,美国妇科肿瘤学会(SGO)发布了妊娠滋养细胞疾病的流行病学,诊断和治疗建议。妊娠滋养细胞疾病(GTD)是由异常受精事件引起的一组相互关联性的肿瘤,包括良性、潜在恶性以及恶性三种情况。, cover=https://img.medsci.cn/2021116/1636175571414_5579292.jpg, journalId=0, articlesId=null, associationId=1177, associationName=美国妇科肿瘤学会, associationIntro=The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers. As a 501(c)(6) organization, the SGO contributes to the advancement of women&rsquo;s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations., copyright=0, guiderPublishedTime=Tue Oct 19 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年10月,美国妇科肿瘤学会(SGO)发布了妊娠滋养细胞疾病的流行病学,诊断和治疗建议。妊娠滋养细胞疾病(GTD)是由异常受精事件引起的一组相互关联性的肿瘤,包括良性、潜在恶性以及恶性三种情况。本文主要针对GTD的流行病学,诊断和治疗提供指导建议。</span></p>, tagList=[TagDto(tagId=1983, tagName=妇科肿瘤), TagDto(tagId=37155, tagName=妊娠滋养细胞疾病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=37155, guiderKeyword=妊娠滋养细胞疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5122, appHits=78, showAppHits=0, pcHits=258, showPcHits=5041, likes=1, shares=31, comments=6, approvalStatus=1, publishedTime=Tue Nov 16 23:57:01 CST 2021, publishedTimeString=2021-10-19, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Nov 06 13:17:29 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 08:29:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 SGO建议:妊娠滋养细胞疾病的流行病学,诊断和治疗.pdf)])
2021 SGO建议:妊娠滋养细胞疾病的流行病学,诊断和治疗.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1202504, encodeId=4dc41202504c2, content=积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:06:15 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072615, encodeId=694610e261530, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd15434064, createdName=ms5000001153711657, createdTime=Sun Nov 21 21:36:15 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070092, encodeId=f15c10e009238, content=谢谢! 但是,积分啊!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:31:04 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068565, encodeId=aaba106856557, content=受益匪浅!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Tue Nov 09 12:45:54 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068118, encodeId=abea1068118ac, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3dd1885795, createdName=ms1812733236525890, createdTime=Mon Nov 08 13:59:46 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2022-03-14 ms4000001244815732

    积分了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1202504, encodeId=4dc41202504c2, content=积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:06:15 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072615, encodeId=694610e261530, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd15434064, createdName=ms5000001153711657, createdTime=Sun Nov 21 21:36:15 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070092, encodeId=f15c10e009238, content=谢谢! 但是,积分啊!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:31:04 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068565, encodeId=aaba106856557, content=受益匪浅!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Tue Nov 09 12:45:54 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068118, encodeId=abea1068118ac, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3dd1885795, createdName=ms1812733236525890, createdTime=Mon Nov 08 13:59:46 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-21 ms5000001153711657

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1202504, encodeId=4dc41202504c2, content=积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:06:15 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072615, encodeId=694610e261530, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd15434064, createdName=ms5000001153711657, createdTime=Sun Nov 21 21:36:15 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070092, encodeId=f15c10e009238, content=谢谢! 但是,积分啊!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:31:04 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068565, encodeId=aaba106856557, content=受益匪浅!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Tue Nov 09 12:45:54 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068118, encodeId=abea1068118ac, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3dd1885795, createdName=ms1812733236525890, createdTime=Mon Nov 08 13:59:46 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-14 陌上咖啡

    谢谢! 但是,积分啊!!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1202504, encodeId=4dc41202504c2, content=积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:06:15 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072615, encodeId=694610e261530, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd15434064, createdName=ms5000001153711657, createdTime=Sun Nov 21 21:36:15 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070092, encodeId=f15c10e009238, content=谢谢! 但是,积分啊!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:31:04 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068565, encodeId=aaba106856557, content=受益匪浅!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Tue Nov 09 12:45:54 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068118, encodeId=abea1068118ac, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3dd1885795, createdName=ms1812733236525890, createdTime=Mon Nov 08 13:59:46 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-09 ms3000001592172450

    受益匪浅!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1202504, encodeId=4dc41202504c2, content=积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411a5486928, createdName=ms4000001244815732, createdTime=Mon Mar 14 16:06:15 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072615, encodeId=694610e261530, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd15434064, createdName=ms5000001153711657, createdTime=Sun Nov 21 21:36:15 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070092, encodeId=f15c10e009238, content=谢谢! 但是,积分啊!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:31:04 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068565, encodeId=aaba106856557, content=受益匪浅!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Tue Nov 09 12:45:54 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068118, encodeId=abea1068118ac, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3dd1885795, createdName=ms1812733236525890, createdTime=Mon Nov 08 13:59:46 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-08 ms1812733236525890

    非常好

    0

拓展阅读

2013 ESMO临床实践指南:妊娠滋养细胞疾病的诊断、治疗与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2013-09-01

妊娠滋养细胞疾病诊断与治疗指南(第四版)

中国抗癌协会妇科肿瘤专业委员会 · 2018-09-10

妊娠滋养细胞疾病诊断与治疗指南(2021年版)

中国抗癌协会妇科肿瘤专业委员会 · 2021-06-25

2021 FIGO《妊娠滋养细胞疾病诊治指南》解读

中山大学孙逸仙纪念医院妇产科 · 2022-02-02

2022 NCCP 临床指南:妊娠滋养细胞疾病(GTD)患者的诊断、分期和治疗

NCCP,National Cancer Control Programme 国家癌症控制计划 · 2022-05-13